| Oxidative stress-related parameters in the liver of non-alcoholic fatty liver disease patients LA Videla, R Rodrigo, M Orellana, V Fernandez, G Tapia, L Quiñones, ... Clinical science 106 (3), 261-268, 2004 | 664 | 2004 |
| CYP1A1, CYP2E1 and GSTM1 genetic polymorphisms. The effect of single and combined genotypes on lung cancer susceptibility in Chilean people L Quinones, D Lucas, J Godoy, D Cáceres, F Berthou, N Varela, K Lee, ... Cancer letters 174 (1), 35-44, 2001 | 178 | 2001 |
| Relationship between in vivo chlorzoxazone hydroxylation, hepatic cytochrome P450 2E1 content and liver injury in obese non-alcoholic fatty liver disease patients M Orellana, R Rodrigo, N Varela, J Araya, J Poniachik, A Csendes, ... Hepatology research 34 (1), 57-63, 2006 | 109 | 2006 |
| Frequencies of 23 functionally significant variant alleles related with metabolism of antineoplastic drugs in the chilean population: comparison with caucasian and asian … Á Roco, L Quiñones, JAG Agúndez, E García-Martín, V Squicciarini, ... Frontiers in genetics 3, 229, 2012 | 104 | 2012 |
| Ethnic susceptibility to lung cancer: differences in CYP2E1, CYP1A1 and GSTM1 genetic polymorphisms between French Caucasian and Chilean populations L Quinones, F Berthou, N Varela, B Simon, L Gil, D Lucas Cancer letters 141 (1-2), 167-171, 1999 | 94 | 1999 |
| Impaired cell cycle regulation of the osteoblast‐related heterodimeric transcription factor Runx2‐Cbfβ in osteosarcoma cells IA San Martin, N Varela, M Gaete, K Villegas, M Osorio, JC Tapia, ... Journal of cellular physiology 221 (3), 560-571, 2009 | 79 | 2009 |
| Joint effect among p53, CYP1A1, GSTM1 polymorphism combinations and smoking on prostate cancer risk: an exploratory genotype‐environment interaction study LA Quiñones, CE Irarrázabal, CR Rojas, CE Orellana, C Acevedo, ... Asian Journal of andrology 8 (3), 349-355, 2006 | 72 | 2006 |
| Study of cytochrome P450 2E1 and its allele variants in liver injury of nondiabetic, nonalcoholic steatohepatitis obese women NM Varela, LA Quiñones, M Orellana, J Poniachik, A Csendes, G Smok, ... Biological research 41 (1), 81-92, 2008 | 54 | 2008 |
| Relationship among metabolizing genes, smoking and alcohol used as modifier factors on prostate cancer risk: exploring some gene–gene and gene–environment interactions DD Cáceres L, J Iturrieta G, C Acevedo C, C Huidobro A, N Varela F, ... European journal of epidemiology 20 (1), 79-88, 2005 | 54 | 2005 |
| The cancer‐related transcription factor RUNX2 modulates expression and secretion of the matricellular protein osteopontin in osteosarcoma cells to promote adhesion to … F Villanueva, H Araya, P Briceno, N Varela, A Stevenson, S Jerez, ... Journal of cellular physiology 234 (8), 13659-13679, 2019 | 52 | 2019 |
| Characterization of the CYP2D6 drug metabolizing phenotypes of the Chilean mestizo population through polymorphism analyses N Varela, LA Quinones, J Stojanova, J Garay, D Cáceres, S Cespedes, ... Pharmacological Research 101, 124-129, 2015 | 46 | 2015 |
| As3MT and GST polymorphisms influencing arsenic metabolism in human exposure to drinking groundwater F González-Martínez, D Sánchez-Rodas, NM Varela, CA Sandoval, ... International Journal of Molecular Sciences 21 (14), 4832, 2020 | 42 | 2020 |
| Clinical applications of pharmacogenomics. L Quiñones, Á Roco, JP Cayún, P Escalante, C Miranda, N Varela, ... Revista médica de Chile 145 (4), 483-500, 2017 | 42 | 2017 |
| Farmacogenética, tabaco, alcohol y su efecto sobre el riesgo de desarrollar cáncer Á Roco, B Cerda, JP Cayun, A Lavanderos, JC Rubilar, R Cerro, ... Revista chilena de pediatría 89 (4), 432-440, 2018 | 37 | 2018 |
| Farmacogenómica como herramienta fundamental para la medicina personalizada: aplicaciones en la práctica clínica L Quiñones, Á Roco, JP Cayún, P Escalante, C Miranda, N Varela, ... Revista médica de Chile 145 (4), 483-500, 2017 | 36 | 2017 |
| In silico Analyses of Immune System Protein Interactome Network, Single-Cell RNA Sequencing of Human Tissues, and Artificial Neural Networks Reveal Potential … A Lopez-Cortes, P Guevara-Ramirez, NC Kyriakidis, C Barba-Ostria, ... Frontiers in Pharmacology 12, 598925, 2021 | 31 | 2021 |
| An updated examination of the perception of barriers for pharmacogenomics implementation and the usefulness of drug/gene pairs in Latin America and the Caribbean A Salas-Hernández, M Galleguillos, M Carrasco, A López-Cortés, ... Frontiers in pharmacology 14, 1175737, 2023 | 30 | 2023 |
| Identification of altered genes in gallbladder cancer as potential driver mutations for diagnostic and prognostic purposes: a computational approach V D’Afonseca, AD Arencibia, A Echeverría-Vega, L Cerpa, JP Cayún, ... Cancer Informatics 19, 1176935120922154, 2020 | 30 | 2020 |
| Frequency of CYP2D6* 3 and* 4 and metabolizer phenotypes in three mestizo Peruvian populations AT Alvarado, R Ybáñez Julca, AM Muñoz, C Tejada Bechi, R Cerro, ... Pensoft Publishers, Bulgaria, 2021 | 28 | 2021 |
| Upregulation of rat liver PPARα‐FGF21 signaling by a docosahexaenoic acid and thyroid hormone combined protocol LA Videla, V Fernández, R Vargas, P Cornejo, G Tapia, N Varela, ... Biofactors 42 (6), 638-646, 2016 | 28 | 2016 |
